AU5498100A - Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions - Google Patents
Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositionsInfo
- Publication number
- AU5498100A AU5498100A AU54981/00A AU5498100A AU5498100A AU 5498100 A AU5498100 A AU 5498100A AU 54981/00 A AU54981/00 A AU 54981/00A AU 5498100 A AU5498100 A AU 5498100A AU 5498100 A AU5498100 A AU 5498100A
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- chemotherapy
- tumor cells
- resistant tumor
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002512 chemotherapy Methods 0.000 title 2
- 239000000203 mixture Substances 0.000 title 2
- 210000004881 tumor cell Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14031099P | 1999-06-21 | 1999-06-21 | |
| US60140310 | 1999-06-21 | ||
| PCT/US2000/016955 WO2000078359A2 (en) | 1999-06-21 | 2000-06-21 | Compositions for treating chemotherapy-resistant tumor cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5498100A true AU5498100A (en) | 2001-01-09 |
Family
ID=22490672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU54981/00A Abandoned AU5498100A (en) | 1999-06-21 | 2000-06-21 | Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU5498100A (en) |
| WO (1) | WO2000078359A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2478543A1 (en) | 2001-10-26 | 2003-04-26 | The Uab Research Foundation | Multidrug multiligand conjugates for targeted drug delivery |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200397A (en) * | 1990-02-22 | 1993-04-06 | W. R. Grace & Co.-Conn. | Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity |
| EP1069137A1 (en) * | 1990-09-24 | 2001-01-17 | W.R. Grace & Co.-Conn. | Peptides having thrombospondin-like activity and their therapeutic use |
| WO1992017499A1 (en) * | 1991-04-08 | 1992-10-15 | Cornell Research Foundation, Inc. | A unique hexapeptide derived from thrombospondin and its uses |
| US5770563A (en) * | 1991-12-06 | 1998-06-23 | The United States Of America As Represented By The Department Of Health And Human Services | Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof |
| US5367059A (en) * | 1992-05-14 | 1994-11-22 | W. R. Grace & Co.-Conn. | Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| AU723614B2 (en) * | 1997-02-13 | 2000-08-31 | Bausch & Lomb Surgical, Inc. | Method for destroying retinal pigment epithelial cells |
| EA200100264A1 (en) * | 1999-06-21 | 2001-10-22 | Филадельфия Хеалс Энд Эдьюкейшн Корпорейшн | ANGIOCIDIN: AN ADHESIVE CELL TUMOR RECEPTOR SPECIFIC FOR CYS-SER-VAL-THR-CYS-GLY |
-
2000
- 2000-06-21 AU AU54981/00A patent/AU5498100A/en not_active Abandoned
- 2000-06-21 WO PCT/US2000/016955 patent/WO2000078359A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000078359A3 (en) | 2002-01-24 |
| WO2000078359A2 (en) | 2000-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003293194A1 (en) | Compositions and methods for treating prostate cancer | |
| AU1656501A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| AU2495200A (en) | Compositions and methods for the treatment of tumor | |
| AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
| AU7994200A (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
| AU5481000A (en) | Combination cancer therapy comprising adenosine and deaminase enzyme inhibitor | |
| AU2003243373A1 (en) | Cell migration inhibiting compositions and methods and compositions for treating cancer | |
| EP1176964B8 (en) | Uses of et743 for treating cancer | |
| MXPA02010866A (en) | Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy. | |
| WO2002030465A3 (en) | Compositions that inhibit proliferation of cancer cells | |
| AU7360000A (en) | Methods and compositions for preventing and treating prostate disorders | |
| AU2001245987A1 (en) | Compositions and methods for gene therapy | |
| AU4033900A (en) | Compositions and methods for treating cell proliferation disorders | |
| AU4823599A (en) | Prostate cancer-associated genes | |
| AU2002308522A1 (en) | Methods for inhibiting tumor cell proliferation | |
| AU2002341749A1 (en) | Methods and compositions for inhibiting the proliferation of prostate cancer cells | |
| AU1916601A (en) | Oncolytic combinations for the treatment of cancer | |
| AU1916501A (en) | Oncolytic combinations for the treatment of cancer | |
| AU8026300A (en) | Sodd gene expression in cancer | |
| AU1917101A (en) | Oncolytic combinations for the treatment of cancer | |
| AU1595001A (en) | Oncolytic combinations for the treatment of cancer | |
| AU2001278068A1 (en) | Methods and compositions for predicting prostate cancer | |
| AU5498100A (en) | Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |